Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of oral methylprednisolone as adjunct therapy in infants with cholestasis
TCTR20221026005Phase 4Unknown
- Sponsor
- Universitas Airlangga
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in cholestasis, sponsored by Universitas Airlangga. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
cholestasis
Beyond the preview
Go deeper on TCTR20221026005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221026005.